AU Patent

AU3108097A — 4-phenylpiperidine compounds

Assigned to Synthon BV · Expires 1998-12-30 · 27y expired

What this patent protects

4-Phenylpiperidine compounds of formula (I) and their salts are new: R = 1-4C alkyl, 1-4C alkynyl, phenyl (optionally substituted by 1-4C alkyl, alkylthio, alkoxy, halo, nitro, acylamino, methylsulphonyl or methylenedioxy) or tetrahydronaphthyl; R1 = H, 1-4C trifluoroalkyl, alkyl…

USPTO Abstract

4-Phenylpiperidine compounds of formula (I) and their salts are new: R = 1-4C alkyl, 1-4C alkynyl, phenyl (optionally substituted by 1-4C alkyl, alkylthio, alkoxy, halo, nitro, acylamino, methylsulphonyl or methylenedioxy) or tetrahydronaphthyl; R1 = H, 1-4C trifluoroalkyl, alkyl or alkynyl; X = H, 1-4C alkyl, alkoxy, trifluoroalkyl, hydroxy, halo, methylthio or aralkoxy; and R2 = 1-10C alkyl, phenyl (optionally substituted by one or more of 1-10C alkyl, halo, nitro, hydroxy and/or alkoxy).

Drugs covered by this patent

Patent Metadata

Patent number
AU3108097A
Jurisdiction
AU
Classification
—
Expires
1998-12-30
Drug substance claim
No
Drug product claim
No
Assignee
Synthon BV
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.